VIVUS, Inc. is the developer and manufacturer of MUSE (alprostadil) and ACTIS, two innovations in the treatment of men with erectile dysfunction, also known as impotence. The Company's objective is to become a global leader in the development and commercialization of innovative therapies for the treatment of sexual dysfunction and urologic disorders in men and women.
VIVUS has completed a Phase III clinical trial for ALIBRA, its second - generation male erectile dysfunction treatment, and expects to file a New Drug Application during the fourth quarter of 1999. The company has initiated a Phase II, proof-of-concept clinical study for the treatment of premature ejaculation, and plans to begin a Phase II clinical study for the treatment of female sexual dysfunction in the first half of 2000.
Welcome to the SI Vivus Thread!
For corporate information: vivus.com |
